PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

111 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
61.
Rauch, J.* et al.: c-Myc regulates RNA splicing of the A-raf kinase and its activation of the ERK pathway. Cancer Res. 71, 4664-4674 (2011)
62.
Mandal, P.K. et al.: Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res. 70, 9505-9514 (2010)
63.
Rauch, J.* et al.: Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription. Cancer Res. 70, 1679-1688 (2010)
64.
Schöllnberger, H. ; Beerenwinkel, N.* ; Hoogenveen, R.* & Vineis, P.*: Cell selection as driving force in lung and colon carcinogenesis. Cancer Res. 70, 6797-6803 (2010)
65.
Torsvik, A.* et al.: Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: Putting the research field on track - letter. Cancer Res. 70, 6393-6396 (2010)
66.
Münz, M.* ; Baeuerle, P.A.* & Gires, O.: The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 69, 5627-5629 (2009)
67.
Nappi, T.C.* et al.: Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. Cancer Res. 69, 1916-1923 (2009)
68.
Røsland, G.V.* et al.: Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 69, 5331-5339 (2009)
69.
Bremm, A.* et al.: Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. Cancer Res. 68, 707-714 (2008)
70.
Luscher-Firzlaff, J.* et al.: The human trithorax protein hASH2 functions as an oncoprotein. Cancer Res. 68, 749-758 (2008)
71.
Ridpath, J.R.* et al.: Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. Cancer Res. 67, 11117-11122 (2007)
72.
Zimmermann, S. et al.: Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res. 67, 9047-9054 (2007)
73.
Kausche, S.* et al.: Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8plus T cells. Cancer Res. 66, 11447-11454 (2006)
74.
Nojima, K.* ; Arakawa, H. & Buerstedde, J.-M.: Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res. 65, 11704-11711 (2005)
75.
Zhou, X.* et al.: Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine. Cancer Res. 65, 1079-1088 (2005)
76.
Felix, K.* et al.: Moderate Hypermutability of a Transgenic lacZ Reporter Gene in Myc-Dependent Inflammation-Induced Plasma Cell Tumors in Mice. Cancer Res. 64, 530-537 (2004)
77.
Felix, K.* et al.: Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice. Cancer Res. 64, 2910-2917 (2004)
78.
Geigl, J.B.* et al.: Analysis of gene expression patterns and chromosomal associated with aging. Cancer Res. 64, 8550-8557 (2004)
79.
Hermann, F.* et al.: HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway. Cancer Res. 64, 215-220 (2004)
80.
Mancuso, M.* et al.: Basal cell carcinoma and its development: Insights from radiation-induced tumors in Ptch1-deficient mice. Cancer Res. 64, 934-941 (2004)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮